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Abstract — Aims: To compare the mortality of female alcoholics randomly assigned to the woman-only programme ‘Early treat-
ment for Women with Alcohol Addiction’ (EWA) versus those who received mixed gender ‘Treatment As Usual’ (TAU). Methods:
Randomized controlled trial involving 2-year follow-up by personal interview and mortality register data through 27 years of 200
women first time treated for alcohol use disorder (AUD; EWA, n=100 and TAU, n=100), who were consecutively recruited during
1983–1984. Data from the Causes of Death Register were used to test for mortality differences related to group interaction predictors
such as age, inpatient versus outpatient status at intake and 2-year drinking outcome. Results: Significantly lower mortality was
found among younger women who participated in EWA compared with those who received TAU. This difference lasted nearly 20
years after intake to treatment. For women who only needed outpatient treatment, reduced mortality was found in the EWA group,
even for older women. Increased mortality was found for TAU women who did not attend the 2-year follow-up compared with those
who attended; no such difference was found for EWA women. This indicates different attrition mechanisms in the two groups. Thus,
previously reported treatment effects may have been underestimated. EWA was a more comprehensive programme than TAU while
also being single gender. Conclusions: EWA, specifically developed to meet a broad spectrum of problems among women with
AUDs, was more effective than TAU, a mixed gender programme. It was not possible to separate whether this was in part because it
was a more comprehensive programme, as well as being single gender.
INTRODUCTION
Female alcoholics show a higher mortality risk than male
alcoholics and women from the general population
(Dahlgren and Myrhed, 1977). The mortality rates reported
vary between 3 and 5.6 for treatment samples (Berglund,
1984; Cipriani et al., 2001; Gerdner and Berglund, 1997;
Lindberg and Ågren, 1988), while it is only 1.4 for women
and men who initiated help seeking for alcohol use disorders
(AUDs; Timko et al., 2006). In a previous study, a mortality
rate of 2.4 was found for 420 women referred to the pro-
gramme ‘Early treatment for Women with Alcohol
Addiction’ (EWA) compared with matched women from the
general population (Haver et al., 2009). In this paper, we
present long-term mortality for a subgroup of these women
(n=200) who participated in a randomized controlled trial
(RCT) that compared the EWA programme with treatment as
usual (TAU).
Treatment variables relevant for mortality are treatment
duration, the need of inpatient versus outpatient treatment
and duration of outpatient follow-up (James, 2005;
Masudomi et al., 2004; Timko et al., 2006). After controlling
for background factors, mortality risk is related to compli-
ance with treatment and intervention outcome as measured
by abstinence, alcohol consumption, social drinking, relapse
and prolonged alcohol misuse after treatment (Barr et al.,
1984; Feuerlein et al., 1994; Gerdner and Berglund, 1997;
Smith et al., 1983, 1994; Taylor, 1994; Timko et al., 2006).
Continuous abstinence may be especially important for survi-
val (Gerdner and Berglund, 1997; Yoshino et al., 1997).
However, alcohol-dependent and socially unstable women
who had an improved drinking pattern, even while not
becoming abstinent, survived longer than the non-improved
women (Gerdner and Berglund, 1997).
There are several reasons to expect differences in long-
term mortality between the EWA and TAU groups. First, the
EWA intervention group did significantly better than the
TAU group on treatment compliance and treatment duration,
needed less inpatient care because they did not experience
relapse drinking following initial treatment, experienced
more improved social conditions and work status, and had a
lower load of psychiatric symptoms at the 2-year follow-up
(Dahlgren and Willander, 1989a). Furthermore, EWA women
had a significantly better drinking outcome as assessed by
self-reported alcohol consumption measures (e.g. total
alcohol consumption, abstinence or meeting the criteria for
social drinking versus drinking relapse). Most importantly,
this initial study reported a trend towards higher mortality
among the TAU women following intake, while the EWA
group had a mortality rate as expected among women of the
general population (Dahlgren and Willander, 1989b). This
important observation needed to be studied for extended
time periods since a potentially lower mortality rate over
time would be a strong indicator of the effectiveness of the
EWA treatment programme.
The preventive effect of an intervention will most likely
be stronger directly after the intervention than it will be in
the long term (Cuijpers et al., 2004). Consequently, the prac-
tice of using the ratio between number of deaths and number
of years when comparing results across different study inter-
vals is a problematic procedure (Timko et al., 2006). It is
unlikely that the same group differences will be consistent
over such a long period of time as 27 years. We expected
women in the EWA group to show increased survival relative
to women in the TAU group, with the most marked differ-
ences early in the follow-up period. Testing such a research
problem can be done by testing whether the group difference
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separate time intervals.
Age should also be taken into account when studying
group differences in mortality, especially when there is a
wide age range. Increasing age is associated with increased
risk of death, and therefore stronger mortality differences are
likely between younger and older women over a long
follow-up period. This makes the interaction between age
and treatment condition (EWA versus TAU) a relevant factor
in the analyses. Age can also act as an indirect predictor of
mortality because it may correlate with other factors relevant
for mortality. For example, older individuals may be less
drug dependent at baseline than younger individuals and
they may also show longer retention in treatment and thereby
are less likely to have close family or friends who encourage
alcohol use (Satre et al., 2004); such factors could poten-
tially moderate some of the direct effects of age on mortality.
The primary research question was whether the same
specific subgroup of women involved in the 2-year RCT,
who received the EWA treatment programme, showed
reduced mortality risk over time compared with the women
who were randomized to TAU (Dahlgren and Willander,
1989a,b). We expected the most marked differences early in
the follow-up period and among the younger women.
The secondary research question was whether mortality
differences between EWA and TAU were related to the need
for inpatient treatment. This is important because inpatient
treatment indicates a more serious alcohol problem. A third
question was whether women who dropped out of the
follow-up study lived as long as those who complied with
the follow-up procedure. The mortality register gives a
unique opportunity to explore this topic. These analyses can
reveal if subjects who drop out are similar to compliant sub-
jects (McKnight et al., 2007; Schafer and Graham, 2002). If
such differences are found, this could indicate an over or
underestimation of the earlier documented treatment outcome
effect (Dahlgren and Willander, 1989a). The fourth research
topic was to explore the relationship between short-term
drinking outcome and mortality.
MATERIALS AND METHODS
Background
The programme ‘Early treatment for Women with Alcohol
Addiction’ was developed in Sweden during the 1980s to
improve existing treatment and to reach women early in their
addiction career by facilitating treatment entry and making
treatment attractive and effective (Dahlgren and Willander,
1989a; Haver and Franck, 1997). The need for a programme
that targeted women was made clear by the observations of a
general increase in alcohol consumption among women and
the poorer treatment results and higher mortality among
women alcoholics coming for treatment compared with that
of men found in earlier studies (Dahlgren, 1979). The lack of
treatment programmes aimed at this specific group of women
called for the development of a more complex and adjusted
intervention programme (Dahlgren, 1979; Dahlgren and
Willander, 1989a; Haver, 2003; Haver and Franck, 1997;
Haver et al., 2001). It was assumed that women would
benefit from more focus on psychiatric symptoms that com-
plicate the alcohol problem and their relationship with their
partner who also frequently had a drinking problem. In
addition, the programme addressed their children’s needs,
the women’s work and their social situations (Dahlgren,
1989).
The EWA treatment
The EWA treatment was conducted at the EWA unit, located
at Magnus Huss Clinic, at the Karolinska Hospital. The
EWA unit was better staffed in general, specifically with
more doctors and psychologists, than the units where TAU
was delivered. Individualized treatment consisted of detoxifi-
cation, inpatient treatment when necessary, psychotropic
drugs and disulfiram (Antabus) according to initial evalu-
ation, individual and women-only group therapy two or three
times a week, regular contact with primarily one of the staff
at the hospital for up to 2 years after initial evaluation, work
training and physiotherapy. The programme also focused on
the woman in her context: family situations and child issues
were approached in co-operation with a child psychiatrist.
The women’s partner was invited to participate in the treat-
ment. Abstinence was the ultimate goal of treatment, though
social drinking was considered as an option when abstinence
was not possible (Haver and Franck, 1997).
TAU interventions included regular contact with nursing
staff and medication administration—first and foremost disul-
firam—after detoxification in inpatient or outpatient care.
The TAU treatment took place in the regular wards at the
same alcoholism treatment centre (Magnus Huss Clinic) or a
nearby outpatient clinic. TAU women were given the same
comprehensive evaluation of drinking patterns, somatic and
mental health status and work and social status at intake.
This description of the TAU treatment condition relies upon
the original papers (Dahlgren and Willander, 1989a,b) and
interviews with two staff members who worked at the ward
during the planning phase of this study. The treatment lasted
on average 8 months for the EWA women and 5 months for
the TAU women (median, P <0.01), and 36% of the EWA
group and 21% of the TAU group continued for 12 months
or more (P <0.05; Dahlgren and Willander, 1989a).
Sample
Two hundred women not previously treated for AUD were
consecutively recruited to an RCT during 1983–1984.
Women with odd dates of birth were assigned to the EWA
programme (n =100), and women with even dates of birth to
a mixed gender setting with no programme specifically
developed for women, here called TAU (n =100). Signs of
chronic alcoholism (liver cirrhosis, dementia), previous treat-
ment for alcohol problems, psychotic syndromes and use of
narcotic drugs were regarded as exclusion criteria in both
treatment groups. Information regarding how many women
refused randomization is not available. However, the groups
did not differ on important clinical data relevant for
outcome. The EWA and TAU women were compared by
more than 200 medical and social variables. Three statisti-
cally significant differences were found: more EWA than
TAU women lived with a male partner and more EWA
women reported signs of more advanced alcohol problems.
This number of statistically significant differences may be as
expected (Dahlgren and Willander, 1989a). In addition, the
authors were uncertain about the advantage of these
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at intake to treatment was 42.4 years (SD 9.82) for both
groups. The study was approved by the Stockholm Regional
Ethical Review Board and the Swedish Data Inspection
Board.
Attrition
In this study, 25 EWA women and 32 TAU women dropped
out at the 2-year personal follow-up, which left a sample of
75 and 68 women, respectively. Reasons for dropout were
refusal to participate because the interview would revive
unpleasant memories or because the interview would make a
new partner who did not know of their earlier problems
aware of their past. Furthermore, some had acquired an unre-
gistered address and telephone number, which prevented the
research team from locating them. Analyses showed that
EWA women with missing observations at follow-up had
somewhat higher wine consumption, but lower liquor con-
sumption, at baseline than EWA women with observations at
follow-up. No such differences in drinking pattern were
found for TAU women. However, TAU women with missing
observation at follow-up consumed less psychotropic medi-
cation at baseline than TAU women who contributed at both
measurement points. The analyses show whether data are
‘missing at random’, but not if data are ‘missing not at
random’ (McKnight et al., 2007; Schafer and Graham,
2002). Register data were available for all women, giving a
unique opportunity to analyse dropout status versus
mortality.
Measures
The variables used in the analyses were age at intake to treat-
ment (continuous variables), inpatient versus outpatient treat-
ment (inpatient treatment needed: 38 of 77 EWA and 25 of
83 TAU women, 40 subjects had missing data in this vari-
able), 2-year treatment outcome and follow-up attrition.
Since very few women in our study reported total abstinence
during the initial 2-year follow-up period, this factor could
not work as a predictor of mortality. Social drinking was
defined as drinking in the company of others, drinking
limited to a pre-decided quantity, absence of craving, no
drinking the following day and consuming <30 g of pure
ethanol (about half a bottle of table wine) in 24 h. Drinking
patterns not in accordance with the above definition were
labelled relapse drinking.
Statistical analysis
Statistical analyses were descriptive statistics, cross tabulation
and survival models (Kaplan–Meier, Cox regression). With
such a long follow-up period, a simple cross tabulation
between group membership and mortality status would most
likely not give statistically significant results. This is not pri-
marily related to lack of statistical power, but to the use of
analysis that does not take time until death into account.
Differences between the groups manifest early in the
follow-up period can be expected to even out over time due
to more deaths later on in the group with lower mortality—
all will die eventually. Nevertheless, the two groups may be
very different regarding years of survival. This problem is
handled by using statistical analyses that incorporate
information about time until death and allow for variance in
group differences over time. Thus, the proportional hazard
assumption underlying ordinary Cox regression will probably
not hold for the 27-year observation period (Schemper,
1992). Cox regression log-minus-log plots and Kaplan–
Meier plots for the two groups showed unparallel lines,
which indicated that ordinary Cox regression is problematic.
Therefore, the factors were entered as time-dependent covari-
ates to allow non-proportional hazards over time. Finding
factors to be time-dependent represents additional evidence
against the proportional hazard assumption. Thus, estimated
hazard ratios (HR) based on a model with both time-
independent and time-dependent covariates are presented
(Bellera et al., 2010). These results revealed a more limited
time interval for further ordinary Cox regression analysis.
All mortality analyses controlled for age and incorporated
age and treatment condition interaction. The variable Age
was used as a continuous variable in all analyses and was
never categorized into age subgroups. To present the inter-
action effect between treatment and age found in the multi-
variate Cox regression analyses, survival plots were
generated at three arbitrary age levels; here they are presented
as plots for women being 30, 40 and 50-years old. Such pre-
diction of outcome values represents standard regression pro-
cedure. Re-analysing this interaction model with centred
variables or with a residualized interaction term would
reduce multi-colinearity between the main predictors and the
interaction predictor, but would not change the interpretation
of the results (Wu and Zumbo, 2008). In contrast to analyses
with the age variable in its original form, a statistically sig-
nificant effect of age was found when centred variables were
used. However, as long as the interaction effect is found to
be statistically significant, this shows that the group differ-
ence is dependent on the age level (Pedhazur and Schmelkin,
1991). In our study, this was confirmed by identical survival
profiles for the different statistical models.
RESULTS
The overall mortality for the total follow-up period of 27
years in the EWA group was 38% and 45% in the TAU
group, a difference that is not statistically significant (χ
2=
1.00; P= 0.32). Cox regression with time-dependent covari-
ates showed statistically significant differences in mortality
between the two intervention groups, depending on age and
time since intake to treatment. Table 1 shows all variables
except the main effect of age to be statistically significant.
Table 1. Cox regression with treatment condition (EWA and TAU), age at
intake, interaction effect between age and treatment condition and time
interaction covariates for the 27-year follow-up period
Variable B Exp(B)
95% CI
lower
95% CI
upper P-value
Treatment (EWA/TAU) −6.51 0.00 0.00 0.37 0.020
Age at intake −0.02 0.98 0.92 1.04 0.495
Age at intake×
Treatment
0.13 1.14 1.14 1.27 0.030
Treatment×Time 0.35 1.42 1.42 1.95 0.032
Age at intake×Time 0.00 1.00 1.00 1.01 0.039
Age at intake×
Treatment×Time
−0.01 0.99 0.99 1.00 0.043
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dependent hazard ratios—HR(t). The plot shows equal and
increasing HRs developing over time for women who are
50-year old. Differences in mortality were found in favour of
the EWA programme for younger women (here shown as
predicted estimates for women who are 30-year old) and for
extended parts of the observation period. This difference
lasted up to 15 years, but levelled out over time, so that no
difference existed ~20 years after intake to treatment.
Since differences in mortality were shown for younger
women up to and slightly above 15 years after intake, a stan-
dard proportional hazard model was analysed for this period
to simplify the model. The results confirmed statistically sig-
nificant effects of treatment condition (EWA versus TAU)
and the interaction between treatment condition and age
[Age at intake: Exp(B)=1.01; P= 0.58; Group effect: Exp
(B)=0.01; P= 0.01; Group× Age: Exp(B)=1.10; P =0.02].
Survival plots showed that mortality group differences were
strongest among younger women, while no difference in sur-
vival was found if the women were ~51-years old as shown
in Fig. 2.
No differences between the two treatment conditions were
found for inpatients versus outpatients over the first 15 years
of observation. A further restriction of the follow-up interval
to 10 years revealed statistically significant interaction effects
of both age and outpatient versus inpatient status with treat-
ment condition [EWA and TAU; Age×Treatment Condition:
Exp(B)=1.36; P =0.007; Treatment condition ×Inpatient
versus Outpatient status: Exp(B)=23.96; P= 0.025]. In
addition, the main effect of treatment condition was statisti-
cally significant [Exp(B)=0.00; P =0.006]. Fig. 3 shows
survival plots for the treatment condition, dependent on inpa-
tient versus outpatient status, and age at intake, with two age
levels to facilitate the illustration. This figure illustrates the
reduced mortality risk among younger EWA women, both in
outpatient and inpatient settings, and among middle-aged
EWA women who received outpatient treatment only.
In the TAU group, Kaplan–Meier analyses showed higher
mortality for women (n=32) who did not complete the
2-year follow-up compared with those who did (n=68;
Generalized Wilcoxon χ
2=14.46; P=0.000), with estimated
mean survival 16.74 and 23.52, respectively. No such survi-
val difference was found among EWA women non-
completers versus completers (n=25 of 75; 22.64 and 21.84
years, respectively, χ
2=0.06; P= 0.81).
A social drinking pattern during 1 or 2 years after intake
was obtained by almost half the EWA group (47.9%), while
the frequency in the TAU group was only 19.1%, a statisti-
cally significant difference (χ
2=13.03; P =0.000). However,
we did not find statistically significant relationships between
social drinking outcome and mortality for the total group of
women who completed the 2-year follow-up (n=143; χ
2
=.076; P =0.38). For those women who did not attain a
social drinking pattern, we nevertheless found that the EWA
women had lower mortality [Age at intake: Exp(B)=0.97;
P =0.396; Group effect: Exp(B)= 0.00; P=0.000; Group ×
Age: Exp(B)=1.56; P =0.002].
DISCUSSION
Reduced mortality was found in the EWA group compared
with the TAU group, with a stronger difference between
younger women in the two groups and with the greatest
difference in the initial period of the total 27-year follow-up
time. This difference was reduced to zero ~20 years after
intake to treatment. Since the two samples were found to be
equal concerning important clinical data relevant for
outcome (Dahlgren and Willander, 1989a), this finding sup-
ports the interpretation that the EWA treatment programme
was more effective than the TAU programme. Few treatment
programmes for female alcoholics have been tested within a
long-term follow-up design, and none to our knowledge with
a randomized controlled design (Greenfield et al., 2007a, b).
Fig. 1. Hazard ratio over time [HR(t)] based on Cox regression with
time-dependent covariates (HR(t)=e
(−6.51 Group−0.02 Age + 0.13 Group × Age + 0.35
Group × Time + 0.00 Age × Time − 0.01 Age × Group × Time)). Age was treated as a
continuous variable. The plot is based on pre-specified values for treatment
group condition and age (30 and 50 years), and the interaction between
treatment condition and age.
Fig. 2. Survival plots for 15-year follow-up after intake to treatment for two
treatment conditions (EWA and TAU) at three different age levels (Cox
regression model estimates). Age was treated as a continuous variable.
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parative effectiveness of the two types of interventions. Since
mortality is a common prognostic and treatment outcome
variable for disorders, improved survival for the younger
women up to ~20 years after the start of treatment is an
important finding.
This finding could be attributed to the fact that the EWA
intervention programme focused on several risk factors for
premature death, such as premature treatment closure
(Berglund et al., 2003; Costello, 2006), level of alcohol con-
sumption, binge drinking and severity of alcohol dependence
symptoms (Timko et al., 2006). The EWA programme also
focused on medical problems, history and presence of mental
health problems, coping strategies and relapse prevention
and interpersonal stressors such as work-related problems
and living with a partner who is a heavy drinker. These and
other factors, like co-habitant status, socio-demographic
status and unemployment, are found to be related to
mortality in the general population and also among female
alcoholics (Feuerlein et al., 1994; Greenfield et al., 2002,
2007a; Lantz et al., 1998; Mann et al., 2004; Masudomi
et al., 2004; Satre et al., 2004; Schneider et al., 1995; Timko
et al., 2006). We believe that longer treatment duration, more
stable contact with treatment staff, targeting premature treat-
ment attrition, focus on medical and psychiatric problems
and the improved short-term outcome are important factors
for the long-term results regarding mortality among EWA
women. Accepting the individual woman’s drinking goal—
without pushing total abstinence as the one and only accepta-
ble outcome—might have enhanced treatment compliance,
and thereby duration of treatment. On the other hand, the
TAU treatment only included supportive counselling in com-
bination with social interventions, and sometimes also medi-
cation. Specific interventions targeting psychiatric
co-morbidity were not generally available outside the EWA
programme at that time, and this aspect of treatment was
later shown to be important for the outcome (Berglund et al.,
2003; Greenfield et al., 2007a; Schneider et al., 1995). In
sum, the EWA treatment programme was more comprehen-
sive and intensive than the TAU treatment and this difference
was important for survival.
Treatment seeking and compliance were facilitated by
attending a woman-only programme (Haver and Franck,
1997); however, the impact of this aspect of treatment setting
on the outcome cannot be measured using the present
design; nevertheless, it is noteworthy that EWA women
reported that meeting other women with drinking problems
was the most important factor related to positive change
(Swedenhammar and Franck, 1995). Another interesting
finding from the original follow-up study is that TAU
women more often changed partners during the first 2 years
after intake to treatment, which might be a result of easier
Fig. 3. Survival plots for 10-year follow-up after intake to treatment for two treatment conditions (EWA and TAU) at two age levels, separated by inpatient
versus outpatient status at intake (Cox regression model estimates). Age was treated as a continuous variable.
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gender programmes has previously been related to a poorer
outcome for women alcoholics (Greenfield et al., 2002).
The main effect of age over the total observation period
was not statistically significant in several analyses; however,
this is of no importance as long as the interaction between
age and treatment condition was found to be statistically sig-
nificant (Pedhazur and Schmelkin, 1991). As expected, this
interaction effect showed that the women’s age was a rel-
evant mortality predictor (Satre et al., 2004; Timko et al.,
2006), but to a different degree for the two groups. Of par-
ticular importance is that the EWA programme improved sur-
vival among younger women, since more years lost to life
were thereby saved. Because mortality differences will level
out over time, we used survival analysis with time-dependent
covariates to analyse differences between the two treatment
conditions. Otherwise, the long-observation period would
have concealed important group differences (Cuijpers et al.,
2004; Schemper, 1992). This procedure also tests the pres-
ence of the proportional hazard assumption, which is not
often verified in research (Bellera et al., 2010), thereby
revealing the important results reported above.
Another finding was related to inpatient versus outpatient
status at intake. Even when initial inpatient treatment was
used, a positive effect of the EWA intervention was found.
In general, the need for inpatient treatment is assumed to
reflect problem severity among female alcoholics (James,
2005; Timko et al., 2006). In the EWA study, missing
data, different practices and availability of inpatient beds
between the EWA and TAU programme make the interpret-
ation of these results uncertain. For patients who received
outpatient treatment only, a lower mortality risk was
observed both among younger and older EWA women,
which shows that the EWA programme also worked for
older women.
Regarding attrition, we found some interesting survival
differences between women who attended the 2-year
follow-up versus those who did not. In the TAU group,
women who dropped out of the study had a higher mortality
compared with those who participated at follow-up. This
indicates that TAU women dropping out of the study were
less well functioning during the observation period. Also,
these findings indicate different attrition mechanisms in the
two groups. We cannot explain this difference because there
is no data for the 2-year follow-up for women who dropped
out of the study. Several factors may be involved: alcohol
relapses, reduced social support systems, meeting new
heavy-drinking partners and ineffective coping strategies. No
such mortality difference was found among the EWA
women. Thus, follow-up attrition was probably ‘not random’
in the TAU group as opposed to the EWA group. In spite of
the increasing focus on missing data theory and method-
ology, it is still not often implemented in research beyond
reporting missing percentages and correlations between miss-
ingness and variables in the study (McKnight et al., 2007;
Schafer and Graham, 2002). Clearly, missing data have
implications for representativeness and generalizations of the
2-year outcome results. The present results reveal that the
findings reported from the original 2-year follow-up study
probably represent an underestimation of the actual initial
outcome differences between the EWA and the TAU samples
(Dahlgren and Willander, 1989a).
The importance of drinking outcome for overall mortality
has been addressed by several authors (Barr et al., 1984;
Feuerlein et al., 1994; Gerdner and Berglund, 1997; Smith
et al., 1994; Taylor, 1994; Timko et al., 2006). In the present
study, relapse drinking during the first 2 years after the start
of treatment did not affect mortality for either the EWA or
TAU group. This could mean that the initial drinking pat-
terns reported are unreliable (Dahlgren and Willander,
1989a). Alternatively, changing drinking patterns during
long-term follow-up is an expected outcome, which makes
the initial drinking outcome an unstable predictor of long-
term mortality. In addition, no difference regarding mortality
was found for women who managed to achieve a socially
acceptable drinking pattern. For those women who did not
attain a social drinking pattern, we nevertheless found that
the EWA programme positively affected mortality. However,
these findings are uncertain due to the reported different attri-
tion mechanisms at the 2-year’s follow-up.
CONCLUSIONS
These results suggest that a woman-only programme specifi-
cally developed to meet a broad spectrum of problems
among women with AUDs could have a major impact on the
lives of these women. The EWA programme had a signifi-
cant effect on mortality over a time period up to 15–20 years
after intake to treatment, especially among younger women,
compared with women who participated in a mixed gender
‘Treatment-As-Usual’ programme.
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